Table 2. A summary of the significant upregulated and downregulated miRNAs, and their relative roles in PDAC carcinogenesis.
| miRNA | Express status | Target genes/signaling pathways | Role in PC | Reference |
|---|---|---|---|---|
| miR-573 | Downregulated | TSPAN1 | Inhibition of PC cell proliferation, colony formation, migration, and invasion, as well as tumor growth suppression in vivo | (8) |
| miR-139 | Downregulated | RalB | Suppression of PC cell growth and metastasis | (20) |
| miR-122-5p | Downregulated | CCNG1 | Proliferation, migration, and invasion are decreased in vitro, and tumorigenesis is prevented in vivo | (21) |
| miR-505 | Downregulated | HK2 | Inhibition of cell proliferation, invasion, sphere formation, glucose consumption, and lactate production | (22) |
| miR-125b | Upregulated | Txnip | Promotion of proliferation and migration | (23) |
| miR-132-3p | Upregulated | Rb1 | Promotion of PC cell growth | (24) |
| miR-543 | Upregulated | STK31 | Promotion of PC cell growth | (25) |
| miR-361-3p | Upregulated | B-cell Translocation Gene 2 | Inhibition of cell proliferation, migration, and invasion, and stimulation of cell cycle arrest and apoptosis | (26) |
| miR-217 | Upregulated | KRAS | The overexpression of miR-217 in a pancreatic tumor cell line lowers KRAS levels, inhibits cell proliferation, and diminishes the constitutive phosphorylation of the downstream signal transducer protein kinase B | (27) |
| miR-27a | Upregulated | Sprouty2 | Promotion of PC cell growth | (28) |
miRNA, micro RNA; PDAC, pancreatic ductal adenocarcinoma; PC, pancreatic cancer; KRAS, kirsten rat sarcoma viral oncogene.